Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -0.58% is 97% above its 5-year average of -18.31%, around the middle of its 5-year range (-101.74%–123.81%).
83.73% above its 12-month average of -3.56%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.41%.
RETURN ON ASSETS (ROA)
-0.58%
RETURN ON ASSETS (ROA) AVG TTM
-3.56%
RETURN ON ASSETS (ROA) AVG 3Y
23.24%
RETURN ON ASSETS (ROA) AVG 5Y
-18.31%
RETURN ON ASSETS (ROA) AVG 10Y
-42.80%
RETURN ON ASSETS (ROA) AVG 15Y
-61.02%
RETURN ON ASSETS (ROA) AVG 20Y
-43.74%
CURRENT VS TTM AVG
+83.73%
CURRENT VS 3Y AVG
-102.50%
CURRENT VS 5Y AVG
+96.83%
CURRENT VS 10Y AVG
+98.64%
CURRENT VS 15Y AVG
+99.05%
CURRENT VS 20Y AVG
+98.67%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+98.20%
vs the sector median at left
TherapeuticsMD, Inc.
Market Cap
$23.26M
Return on Assets (ROA)
-0.58%
TTM Avg
-3.56%
3Y Avg
23.24%
5Y Avg
-18.31%
Market Cap
$22.92M
Return on Assets (ROA)
-75.43%
TTM Avg
-148.63%
3Y Avg
-74.35%
5Y Avg
-49.59%
Market Cap
$23.88M
Return on Assets (ROA)
181.24%
TTM Avg
65.61%
3Y Avg
3.99%
5Y Avg
-7.40%
Market Cap
$22.20M
Return on Assets (ROA)
-248.63%
TTM Avg
-139.76%
3Y Avg
-97.50%
5Y Avg
-68.94%
Market Cap
$22.13M
Return on Assets (ROA)
-228.73%
TTM Avg
-145.44%
3Y Avg
-152.25%
5Y Avg
-187.73%
Market Cap
$22.00M
Return on Assets (ROA)
-13.57%
TTM Avg
-12.25%
3Y Avg
-12.55%
5Y Avg
-25.19%
Market Cap
$24.59M
Return on Assets (ROA)
-116.81%
TTM Avg
-53.20%
3Y Avg
-39.87%
5Y Avg
-35.95%
Market Cap
$24.91M
Return on Assets (ROA)
-40.73%
TTM Avg
-51.29%
3Y Avg
-88.21%
5Y Avg
-85.48%
Market Cap
$25.30M
Return on Assets (ROA)
-86.25%
TTM Avg
-69.34%
3Y Avg
-63.87%
5Y Avg
-58.73%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | $23.26M | -0.58% | -3.56% | 23.24% | -18.31% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.92M | -75.43% | -148.63% | -74.35% | -49.59% |
| Kyntra Bio, Inc. (KYNB)vs › | $23.88M | 181.24% | 65.61% | 3.99% | -7.40% |
| LeonaBio, Inc. (LONA)vs › | $22.20M | -248.63% | -139.76% | -97.50% | -68.94% |
| Modular Medical, Inc. (MODD)vs › | $22.13M | -228.73% | -145.44% | -152.25% | -187.73% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | -13.57% | -12.25% | -12.55% | -25.19% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.59M | -116.81% | -53.20% | -39.87% | -35.95% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.91M | -40.73% | -51.29% | -88.21% | -85.48% |
| InspireMD, Inc. (NSPR)vs › | $25.30M | -86.25% | -69.34% | -63.87% | -58.73% |
| iTonic Holdings Ltd. (ITOC)vs › | $25.78M | -56.04% | -32.94% | -18.68% | -12.05% |
ROA
-0.6%
ROE
-0.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -1.51% |
| 2024-12-31 | -5.62% |
| 2023-12-31 | -23.73% |
| 2022-12-31 | 123.81% |
| 2021-12-31 | -101.74% |
| 2020-12-31 | -101.05% |
| 2019-12-31 | -66.22% |
| 2018-12-31 | -62.56% |
| 2017-12-31 | -53.71% |
| 2016-12-31 | -63.08% |
| 2015-12-31 | -115.39% |
| 2014-12-31 | -91.77% |
| 2013-12-31 | -45.83% |
| 2012-12-31 | -603.64% |
| 2011-12-31 | -897.56% |
| 2010-12-31 | -613.47% |
| 2009-12-31 | -194.71% |
| 2008-12-31 | -726.87% |
| 2007-12-31 | 34.43% |
| 2006-12-31 | 7.29% |
| 2005-12-31 | 17.89% |
| 2004-12-31 | 13.06% |
| 2003-12-31 | 10.48% |
| 2002-12-31 | 13.13% |
| 2001-12-31 | 8.85% |
| 2000-12-31 | 5.04% |
| 1999-12-31 | 2.50% |
| 1998-12-31 | -3.06% |
| 1997-12-31 | -2.52% |
| 1996-12-31 | 14.31% |
